# Bristol-Myers Squibb Company (BMY) — Q1-2021 Earnings Results

**Report date:** 2021-04-29 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q1-2021

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Misses on EPS — Stock Down 4.76%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.74 | N/A | -3.33% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed a cautious optimism about future product launches while recognizing challenges in the current market landscape.

**Key quotes:**

> Management highlighted ongoing commitment to pipeline development.

> They acknowledged competitive pressures in the market.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Bristol Myers Squibb's earnings report shows a slight miss on EPS, which contributed to a notable decline in stock price. Investors may be concerned about the lack of guidance and the competitive pressures mentioned by management. The stock's drop of 4.76% reflects these uncertainties as the company navigates its future strategy.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q1-2021_